FROM VENOM TO MEDICINE: REPTILE TOXINS AS A SOURCE OF THERAPEUTIC INNOVATION
DOI:
https://doi.org/10.26873/SVR-2336-2026Abstract
Natural toxins have for centuries evoked fear, fascination, and scientific curiosity. Today, it is well recognized that reptile venoms are not merely weapons for predation or defense, but also an exceptionally rich source of bioactive molecules with significant potential for drug development. Over millions of years of evolution, complex mixtures of peptides, enzymes, and proteins have emerged that precisely target key physiological pathways, including blood coagulation, neural signaling, metabolism, and cellular communication. This remarkable specificity positions venoms among the most important sources of inspiration for modern translational medicine and emphasizes the importance and power of comparative research.
Od strupa do zdravila: plazilski toksini kot vir terapevtskih inovacij
Izvleček: Naravni toksini že stoletja vzbujajo strah, fascinacijo in znanstveno radovednost. Danes vemo, da strupi plazilcev niso zgolj orožje za lov ali obrambo, temveč predstavljajo izjemno bogat vir bioaktivnih molekul z velikim potencialom za razvoj novih zdravil. Evolucija je skozi milijone let oblikovala kompleksne mešanice peptidov, encimov in proteinov, ki natančno ciljajo ključne fiziološke poti, vključno s strjevanjem krvi, živčnim signaliziranjem, presnovo in celično komunikacijo. Prav ta visoka specifičnost omogoča, da strupi predstavljajo enega najpomembnejših virov navdiha za sodobno translacijsko medicino ter poudarjajo pomen in moč primerjalnih raziskav.
Ključne besede: strupi plazilcev; kačji strupi; translacijska medicina; hemostaza; tromboza; razvoj zdravil; GLP-1; antikoagulanti
References
Cushman DW, Ondetti MA. Design of angiotensin converting enzyme inhibitors. Nat Med 1999; 5(10): 1110–2.
Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 2018; 27(4): 740–56. doi: 10.1016/j.cmet.2018.03.001
Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 1992; 267(11): 7402–5.
Ferreira SH. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca. Br J Pharmacol Chemother 1965; 24(1): 163–9. doi: 10.1016/j.bcp.2020.114096
Fon Tacer, K. Advancing cancer therapies through the one health approach: the role of veterinary and comparative oncology in human and animal patient care. Slov Vet Res 2025; 62(Suppl. 27): 5–7. doi: 10.26873/SVR-2182-202
Herzig V, Cristofori-Armstrong B, Israel MR, Nixon SA, Vetter I, King GF. Animal toxins—Nature’s evolutionary-refined toolkit for basic research and drug discovery. Biochem Pharmacol 2020; 181: 114096.
Kini RM. Toxins in thrombosis and haemostasis: potential beyond imagination. J Thromb Haemost 2011; 9(Suppl. 1): 195–208. doi: 10.1111/j.1538-7836.2011.04279.x
Sajevic T, Leonardi A, Križaj I. Haemostatically active proteins in snake venoms. Toxicon 2011; 57(5): 627–45. doi: 10.1016/j.toxicon.2011.01.006
Tozon, N. (2025). Translation oncology through the one health perspective. Slov Vet Res 62(Suppl. 27): 9–12. doi: 10.26873/SVR-2180-2024
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maša Čater
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
